Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

OPNT Opiant Pharmaceuticals

10.630
+0.470+4.63%
Close 09/28 16:00 ET
High
10.980
Open
10.400
Turnover
133.87K
Low
10.110
Pre Close
10.160
Volume
12.70K
Market Cap
54.89M
P/E(TTM)
Loss
52wk High
37.711
Shares
5.16M
P/E(Static)
20.84
52wk Low
7.340
Float Cap
50.21M
Bid/Ask %
0.00%
Historical High
48.000
Shs Float
4.72M
Volume Ratio
0.62
Historical Low
6.788
Dividend TTM
--
Div Yield TTM
--
P/B
1.85
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.27%
Amplitude
8.56%
Avg Price
10.544
Lot Size
1
Float Cap
50.21M
Bid/Ask %
0.00%
Historical High
48.000
Shs Float
4.72M
Volume Ratio
0.62
Historical Low
6.788
Dividend TTM
--
P/B
1.85
Dividend LFY
--
Turnover Ratio
0.27%
Amplitude
8.56%
Avg Price
10.544
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Santa Monica, CA.
CEO: Dr. Roger Crystal
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...